Insider Selling: Cardlytics, Inc. (NASDAQ:CDLX) CEO Sells 46,857 Shares of Stock

Cardlytics, Inc. (NASDAQ:CDLXGet Free Report) CEO Amit Gupta sold 46,857 shares of the business’s stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $3.40, for a total value of $159,313.80. Following the transaction, the chief executive officer now owns 418,637 shares of the company’s stock, valued at $1,423,365.80. The trade was a 10.07 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Amit Gupta also recently made the following trade(s):

  • On Friday, January 24th, Amit Gupta sold 15,160 shares of Cardlytics stock. The stock was sold at an average price of $3.92, for a total transaction of $59,427.20.
  • On Friday, January 3rd, Amit Gupta sold 5,964 shares of Cardlytics stock. The shares were sold at an average price of $3.67, for a total transaction of $21,887.88.

Cardlytics Stock Down 9.1 %

Shares of CDLX stock opened at $2.69 on Friday. Cardlytics, Inc. has a 12-month low of $2.67 and a 12-month high of $20.52. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 2.40. The firm has a fifty day moving average of $3.42 and a 200-day moving average of $3.69. The company has a market capitalization of $136.71 million, a price-to-earnings ratio of -0.44 and a beta of 1.54.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on CDLX shares. Craig Hallum raised shares of Cardlytics from a “hold” rating to a “strong-buy” rating in a report on Wednesday, November 6th. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a report on Friday, January 17th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $6.92.

View Our Latest Analysis on CDLX

Hedge Funds Weigh In On Cardlytics

A number of large investors have recently added to or reduced their stakes in the company. Tallon Kerry Patrick bought a new stake in shares of Cardlytics in the fourth quarter valued at about $37,000. Atom Investors LP acquired a new stake in Cardlytics in the 3rd quarter valued at approximately $33,000. ProShare Advisors LLC bought a new stake in Cardlytics in the 4th quarter valued at approximately $43,000. SG Americas Securities LLC acquired a new position in Cardlytics during the 3rd quarter worth approximately $45,000. Finally, Intech Investment Management LLC bought a new position in shares of Cardlytics during the 3rd quarter worth approximately $47,000. Institutional investors own 68.10% of the company’s stock.

About Cardlytics

(Get Free Report)

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.

Featured Articles

Insider Buying and Selling by Quarter for Cardlytics (NASDAQ:CDLX)

Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.